AP
RNTX

Americana Partners’s Rein Therapeutics RNTX Stock Holding History

Americana Partners’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.5K Buy
27,302
+10,000
+58% +$12.4K ﹤0.01% 509
2025
Q4 		$20.1K Hold
17,302
– – ﹤0.01% 475
2025
Q3 		$19.8K Hold
17,302
– – ﹤0.01% 457
2025
Q2 		$24.2K Buy
17,302
+6,200
+56% +$11.2K ﹤0.01% 420
2025
Q1 		$19.7K Buy
+11,102
New +$23.3K ﹤0.01% 373

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Americana Partners's RNTX Position: Q1 2026 in Review

Americana Partners increased its Rein Therapeutics (RNTX) stake by 58% in Q1 2026, buying an estimated $12.4K and bringing the position to 27,302 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Americana Partners first reported a position in RNTX in Q1 2025 and has held it in 5 quarters since. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Americana Partners held 27,302 shares of Rein Therapeutics worth $35.5K as of Q1 2026.
  • Americana Partners bought 10,000 Rein Therapeutics shares in Q1 2026, an estimated $12.4K.
  • Rein Therapeutics made up ﹤0.01% of Americana Partners's portfolio in Q1 2026, its #509 holding.
  • Americana Partners first reported a position in Rein Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Americana Partners's 13F filing for Q1 2026, filed 12 May 2026.